Perceptions regarding RSV and RSV immunization among (prospective) parents and older adults.

Respiratory Syncytial Virus (RSV) poses a significant threat to the health of vulnerable populations, such as infants and older adults. Until recently, there were no immunization options available to prevent (severe consequences of) RSV. Last year, two types of immunization products were approved by the European Medicine Agency (i.e., vaccines that can be given to adults and a Monoclonal Antibody injection that can be administered to infants). With the introduction of these new RSV immunization products, countries need to decide on whether and how to implement them in their national vaccination schedule. As general vaccination hesitancy has increasingly become a challenge, it is vital to understand how individuals perceive these immunization products and what they would need to make well-informed decisions. To address this, ReSViNET – an international non-profit organization dedicated to reducing the impact of RSV on global health – funded our study in which we developed and analyzed two questionnaires targeted at (prospective) parents and older adults. This report provides valuable insights into factors that relate to RSV awareness and immunization willingness.